Company profile for GeneQuantum Healthcare

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2013 at BioBay, Suzhou, GeneQuantum Healthcare Co., Ltd. is a global innovative biopharmaceutical company that develops new bioconjugation drugs with differentiated platforms to provide safer, more effective and affordable drugs and treatment options for patients around the world. GeneQuantum brings together well-known experts both at home and from abroad in the fields of biocongujation drug discovery, process deve...
Founded in 2013 at BioBay, Suzhou, GeneQuantum Healthcare Co., Ltd. is a global innovative biopharmaceutical company that develops new bioconjugation drugs with differentiated platforms to provide safer, more effective and affordable drugs and treatment options for patients around the world. GeneQuantum brings together well-known experts both at home and from abroad in the fields of biocongujation drug discovery, process development and cGMP manufacturing and operation, clinical operation and business development. Our vision is to address the critical challenges of the biopharmaceutical industry with differentiated innovations

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Building D, No.398, Ruoshui Road, Suzhou Industrial Park
Telephone
Telephone
(86) 0512-62872890
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/nona-biosciences-announces-strategic-collaboration-with-genequantum-healthcare-to-empower-early-discovery-of-next-generation-bioconjugates-301985807.html

PR NEWSWIRE
13 Nov 2023

https://www.prnewswire.com/news-releases/genequantum-and-inxmed-have-reached-a-technology-licensing-collaboration-providing-strong-support-for-innovative-adc-drug-research-and-development-301878259.html

PR NEWSWIRE
17 Jul 2023
Chinese and Korean biotechs expand ADC collaboration
Chinese and Korean biotechs expand ADC collaboration

07 Jul 2023

// James Waldron FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/buoyed-preclinical-success-chinese-and-korean-biotechs-expand-adc-collaboration

James Waldron FIERCE BIOTECH
07 Jul 2023

https://www.prnewswire.com/news-releases/forge-stronger-partnership-for-advanced-adc-development-genequantum-healthcare-and-aimed-bio-collaborate-to-develop-five-innovative-adc-drugs-301871712.html

PR NEWSWIRE
06 Jul 2023

https://www.indianpharmapost.com/news/genequantum-and-wuxi-xdc-enter-into-strategic-cooperation-to-empower-innovative-bioconjugates-development-13503

INDIANPHARMAPOST
27 Dec 2022

https://www.prnewswire.com/news-releases/genequantum-healthcares-two-next-generation-bioconjugate-drugs-gq1005-and-gq1007-have-been-approved-for-clinical-trials-in-australia-301547439.html

PRNEWSWIRE
15 May 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty